Tenzing Acquisition Corp. (TZAC) to Combine with Reviva Pharmaceuticals

Tenzing Acquisition Corp. (TZAC), announced this morning that they have signed a definitive agreement and plan of merger (the “Merger Agreement”) for a business combination with Reviva Pharmaceuticals, Inc. (“Reviva”), a California-based clinical stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases
Read More